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Abstract
Cytotoxicity and mitochondrial parameters were studied in isolated lymphocytes and their 
mitochondria obtained from occupationally exposed nurses through inhalation exposure to 
antineoplastic drugs and results were compared to those of unexposed nurses. The group of 
occupationally exposed nurses consisted of 50 individuals ranging in age from 30 to 35 years. 
The control group included 50 nurses who were not occupationally exposed to the preparation 
and handling of antineoplastic drugs and their anthropometric and biochemical characteristics 
were similar to those of the expose group. All cytotoxicity and mitochondrial parameters 
evaluated in exposed group were significantly increased (P < 0.05) compared to the unexposed 
control group. Finally, the results of our study suggest that using antioxidant, mitochondrial and 
lysosomal protective agents can be promising drug candidates for the hospital staff in the risk 
of exposure to exposure to antineoplastic drugs.    
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Introduction
Antineoplastic drugs are widely used agents 
for the treatment of cancer. most of these agents act 
by interfer ing directly with the deoxyribonucleic 
acid of tumour cells and thereby intercept 
their growth (1). Unfortunately, antineoplastic 
drugs are generally non-selective and therefore 
healthy cells may also be damaged which, in 
turn, results in toxic effects. Given this, there 
is a risk to healthcare individuals who handle, 
prepare, and administer antineoplastic drugs 
(2). Numerous investigations have examined 
antineoplastic drug contamination in healthcare 
instruments. Studies have demonstrated surface 
contamination of countertops, cabinets and floors 
within the drug preparation area (3). Traceable 
levels of environmental drug contamination 
have also been found in patient care areas. In the 
absence of any current occupational exposure 
limits for antineoplastic drugs, it is therefore 
important to minimize contamination (3). 
More investigations revealed that these surface 
contaminations were within a healthcare facility 
the pharmacy, where the drugs are provided, 
and the administration units where the prepared 
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drugs are given to patients (4). The emphasis on 
these places is warranted since direct handling of 
the drugs is anticipated during both preparation 
and administration (5, 6).
Employees in oncological units may 
experience occupational exposure to low doses 
of anticancer drugs (7). The International 
Agency for Research on Cancer (IARC) has 
classified many anticancer drugs as class 1 
human carcinogens such as cyclophosphamide, 
etoposide, busulfan, melfalan, class 2A probably 
carcinogenic to humans such as azacitidine, 
cisplatin, doxorubicine and class 2B possibly 
carcinogenic to humans such as bleomycin, 
dacarbazine, mitoxantrone, mitomycin (8). 
Occupational exposure to anticancer drugs 
has been shown to result in increased total 
chromosomal aberrations (9-11). Interestingly, 
nurses occupationally exposed to anticancer 
drugs showed an elevated level of not only 
chromatid-type aberrations (CTA), but also 
chromosome-type aberrations (CSA), such as 
chromosome breaks, which is typical of radiation 
exposure (12).
Cancer is one of the leading causes of death 
in the world.  A large percentage of patients are 
diagnosed at an advanced stage, making the 
removal of tumors in this population problematic. 
Therefore, early stage detection would be 
helpful in reducing cancer mortality (13). For 
this reason, a well-established assessment model 
would greatly benefit patients, clinicians, and 
researchers because it would allow individuals 
at high risk to be identified at the earliest stages. 
Accurately assessing cancer risk in average- and 
high-risk individuals is crucial to controlling 
the suffering and death due to cancer. Cancer 
prediction proceedings provide an important 
approach to assessing risk by identifying 
individuals at high risk (13). 
Human peripheral blood lymphocytes 
(PBL) are extensively used in biomonitoring 
of populations exposed to various mutagenic or 
carcinogenic compounds (14). This is because 
of the ease of sampling, the possibility of 
obtaining large numbers of scorable cells (15). 
The conceptual basis for using of toxicity in 
PBL as a biomarker has been the hypothesis 
that the extent of genetic damage in PBL 
reflects similar events in the precursor cells 
for carcinogenic processes in the target tissues 
(16). The aim of this work was to evaluate 
cellular and mitochondrial toxicity parameters 
such as cytotoxicity, reactive oxygen species 
(ROS), mitochondrial membrane potential 
(MMP), lysosomal integrity, glutathione levels, 
lipid peroxidation in the blood lymphocytes of 
oncology nurses occupationally exposed through 
inhalation exposure to anticancer drugs and 
compare the findings with those of unexposed 
hospital nurses. 
Experimental
Cellular Assessments 
Blood samples 
All blood samples (exposed nurses = 50 
and unexposed nurses = 50) were acquired 
and approved by Blood Administration Center. 
Exposed nurses were exposed with anti-cancer 
drugs such as 5- Fluoro Uracil, Methotrexate, 
Cisplatin, Vinblastine and Tamoxifen. The 
studies were performed at the school of Pharmacy, 
Shahid Beheshti University of Medical Sciences, 
under the guidance of an expert physician. 
This study was approved by Shahid Beheshti 
University of Medical Sciences, and all healthy 
individuals signed an informed consent form.
Lymphocytes isolation
Lymphocytes were collected from nurses 
occupationally exposed to anticancer drugs and 
unexposed nurses at age range 30 to 35 years 
old whose anthropometric and biochemical 
characteristics were similar to those of the 
expose group. Blood was obtained from, non-
smoking volunteers, who showed no signs of 
infection disease symptoms at the time that the 
blood samples were collected. Lymphocytes 
were isolated using Ficoll Paque Plus according 
to the manufacturerꞌs instructions. The obtained 
lymphocytes were suspended in RPMI1640 
medium with L-glutamine and 10% FBS. 
The final lymphocytes account used in the 
experiments was 1 × 106 cells/mL. The viability 
of the lymphocytes was over 95% (17, 18). 
Determination of ROS
To determine the rate of lymphocytes ROS 
generation, dichlorofluorescein diacetate (DCFH-
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DA, 1.6 µM) was added to the lymphocytes. It 
penetrates lymphocytes and becomes hydrolyzed 
to non-fluorescent dichlorofluorescein (DCFH). 
The latter then reacts with ROS to form the highly 
fluorescent dichlorofluorescein (DCF), which 
effluxes the cell. The fluorescence intensity of 
DCF was measured using a Shimadzu RF5000U 
fluorescence spectrophotometer. Excitation and 
emission wavelengths were 500 nm and 520 
nm, respectively. The results were expressed as 
fluorescent intensity per 106 cells (17, 19). 
MMP Assay
Mitochondrial uptake of the cationic 
fluorescent dye, rhodamine 123 (1.5 µM), has 
been used for the estimation of mitochondrial 
membrane potential. The amount of rhodamine 
123 remaining in the incubation medium was 
measured fluorimetrically using a Shimadzu 
RF5000U fluorescence spectrophotometer 
set at 490 nm excitation and 520 nm emission 
wavelengths. The capacity of mitochondria to 
take up the rhodamine 123 was calculated as the 
difference (between control and treated cells) in 
rhodamine 123 fluorescence (17, 20).
Lysosomal Membrane Integrity Assay
Lymphocytes lysosomal membrane stability 
was determined from the redistribution of the 
fluorescent dye, acridine orange. Aliquots of the 
cell suspension (0.5 mL) that were previously 
stained with acridine orange (5 µM) were 
separated from the incubation medium by 1 
min centrifugation at 1000 rpm. Cell washing 
process was carried out twice to remove the 
fluorescent dye from the media. Acridine orange 
redistribution in the cell suspension was then 
measured fluorimetrically using a Shimadzu 
RF5000U fluorescence spectrophotometer 
set at 495 nm excitation and 530 nm emission 
wavelengths (17, 21). 
Lipid Peroxidation
Evaluation of lipid peroxidation in 
lymphocytes was conducted by determining the 
amount of thiobarbituric acid reactive substances 
(TBARS) formed during the decomposition 
of lipid hydro peroxides by following the 
absorbance at 532 nm in a Beckman DU-7 
spectrophotometer (17).
GSH and GSSG
GSH and GSSG were determined according 
to the spectrofluorometric method (22). Each 
sample was measured in quartz cuvettes using a 
fluorimeter set at 350 nm excitation and 420 nm 
emission wavelengths.
ADP/ATP ratio Assay 
Changes in the ADP/ATP ratio have been 
used to differentiate modes of cell death and 
viability. ADP/ATP ratio was assessed by ADP/
ATP Ratio Assay kit (MAK135 sigma, USA) in 
lymphocytes using luminometer. ADP/ATP ratio 
was performed according to the manufacturer’s 
instructions (23).
Mitochondrial Assessments 
Lymphocytes Lysis and Isolation of 
Mitochondria
Mitochondria were isolated from the 
lymphocytes by mechanical lysis and differential 
centrifugation. Briefly, lymphocytes were 
washed with cold PBS at 4 ºC and centrifuged 
at 450 × g. The pellet was resuspended in cold 
isolation buffer (75 mmol/L sucrose, 20 mmol/L 
HEPES, 225 mmol/L mannitol, 0.5 mmol/L 
EDTA, pH 7.2), and the cells were disrupted 
by homogenization. Nonlysed lymphocytes and 
nuclei were spun down by centrifugation at 750 
× g for 20 min. The supernatant was further 
spun at 10,000 × g for 10 min twice. The pellet, 
designated as the mitochondrial fraction, was 
suspended in assay buffer (140 mmol/L KCl, 10 
mmol/L NaCl, 2 mmol/L MgCl2, 0.5 mmol/L 
KH2PO4, 20 mmol/L HEPES, 0.5 mmol/L 
EGTA; adjusted to pH 7.2 with KOH) (24, 25).
Succinate Dehydrogenases Activity 
Complex II Enzyme Activity was measured by 
Complex II Enzyme Activity Microplate Assay 
Kit (ab109908, United Kingdom). Each well in 
the kit has been coated with an anti-Complex 
II monoclonal antibody (mAb) which purifies 
the enzyme from a complex sample. After this 
in-well purification the production of ubiquinol 
by the enzyme is coupled to the reduction of 
the dye DCPIP (2,6-diclorophenolindophenol) 
and a decreases in its absorbance at 600 nm, 
which in turn recycles the substrate ubiquinone 
(26).
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Mitochondrial Swelling Assay 
Mitochondria suspensions (at 100 µg protein 
per well) were incubated in 96-well plates at 
25 ºC in swelling buffer (140 mmol/L KCl, 
10 mmol/L NaCl, 2 mmol/L MgCl2, 0.5 
mmol/L KH2PO4, 20 mmol/L HEPES, 0.5 
mmol/L EGTA; adjusted to pH 7.2 with KOH) 
supplemented with 1 mg/mL rotenone and 10 
mmol/L succinate. Mitochondrial swelling was 
measured spectrophotometrically in duration 1 
h. Mitochondrial swelling results in a decrease 
in absorbance monitored at 540 nm (27).
Cytochrome C Release Assay  
The concentration of cytochrome C was 
determined through using the Quantikine Human 
Cytochrome C Immunoassay kit (Minneapolis, 
Minn). Cytochrome C measurement was 
performed according to the manufacturer’s 
instructions (28).
Statistical Analysis
Statistical analyses were performed by 
GraphPad Prism 6. Results were presented as 
mean ± SED. Assays were performed in triplicate 
and the mean was used for statistical analysis. 
All graphs were expressed as mean ± SEM 
and P < 0.05 was considered statistically 
significant. 
Results
ROS formation 
There is equilibrium between ROS 
formation and endogenous antioxidant defense 
mechanisms, but if this balance is disturbed, 
it can produce oxidative stress. As shown in 
Figure 1A, isolated lymphocytes from oncology 
nurses in comparison with healthy unexposed 
individuals showed significant increase at ROS 
formation. 
MMP Collapse 
To monitor the mitochondrial membrane 
potential, lymphocyte mitochondria were stained 
with rhodamine 123. Isolated lymphocytes from 
oncology nurses in comparison with healthy 
unexposed individuals showed a significant 
collapse at the mitochondrial membrane 
potential. These changes were in the accordance 
with the order of ROS formation of the isolated 
lymphocytes from oncology nurses (Figure 1B).
Lysosomal Integrity 
As shown in Figure 2A there was a loss 
of lysosomal membrane integrity measured 
by redistribution of fluorescent dye acrdine 
orange in the lymphocytes isolated from nurses 
occupationally exposed to anticancer drugs. 
 
 
 
 
 
 
 
 
 
 
 
Figure 2 
Figure 1. ROS formation (A) and MMP collapse (B) assay in lymphocytes. ROS formation was measured fuorometrically using DCF-
DA as described in materials and methods. Also collapse of MMP was measured by rhodamine 123 as described in materials and 
methods. Each bar represents mean ± SEM. Each group consisted of 50 individuals. *** p ˂ 0.001 significant difference compared to 
the unexposed group.
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While no significant lysosomal damage was 
detected in lymphocytes isolated from healthy 
unexposed nurses.
ADP/ATP ratio
ATP and ADP were measured using a 
bioluminescence assay based on luciferin/
luciferase reaction. The ADP and ATP were 
measured at both groups (Figure 2B). As shown 
in Figure 2B there was a significant decrease in 
ATP and a significant increase in ADP levels 
only in lymphocytes isolated from oncology 
nurses (P < 0.05) while no significant changes at 
ADP/ATP ratio observed in healthy unexposed 
staff lymphocytes. 
Lipid Peroxidation and Glutathione Levels
Lipid per-oxidation in lymphocytes was 
determined by measuring MDA formation. As 
shown in Figure 3, significant MDA formation 
only observed in the lymphocytes isolated from 
nurses occupationally exposed to anticancer 
drugs. While no significant MDA formation was 
detected in lymphocytes isolated from healthy 
unexposed nurses.
In addition, as shown in Figure 3 reduced 
(GSH) and oxidized (GSSG) glutathione levels 
were determined under the same experimental 
conditions and correlated with MDA formation 
and other measured parameters. A significant 
decrease in reduced glutathione (GSH) level 
was observed in the lymphocytes isolated from 
nurses occupationally exposed to anticancer 
drugs followed by a significant increase of 
oxidized (GSSG) glutathione levels compared 
to those of healthy unexposed staff under the 
similar condition.
Mitochondrial Assessment 
SDH Activity
Evaluations of SDH Activity in isolated 
mitochondria obtained from both oncology and 
healthy nurses were carried out by studying 
succinate dehydrogenase activity using the 
Complex II Enzyme Activity Microplate 
Assay Kit. Succinate dehydrogenase activity 
significantly reduced only in mitochondria from 
oncology but not in healthy unexposed nurses’ 
lymphocytes (Figure 4A). 
Mitochondrial Swelling
Mitochondrial swelling has been considered 
as an indication of the opening of the MPTP, 
which results in depolarization of mitochondrial 
Figure 2. Lysosomal membrane damage (A) and ATP level (B). Human lymphocytes (106 cells/mL) were suspended in the RPMI 1640 
at 37  oC. Lysosomal membrane damage was determined as the difference in redistribution of acridine orange from lysosomes into 
cytosol between both groups. ATP/ADP ratio were determined by Luciferin /Luciferase assay System as described in Materials and 
Methods.  Each bar represents mean ± SEM. Each group consisted of 50 individuals. *** p ˂ 0.001 significant difference compared to 
the unexposed group.
 
 
 
 
 
 
 
 
 
Figure 3 
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membrane potential. We observed that 
mitochondrial swelling occurred only in 
mitochondria obtained from oncology but 
not healthy unexposed nurses’ lymphocytes. 
We also recorded mitochondrial membrane 
potential decrease using rhodamine 123 and 
ROS formation using DCF-DA in the isolated 
mitochondria obtained from blood lymphocytes 
of both groups (data not shown) (Figure 4B). 
Cytochrome C Release 
The process of cell death involves the 
release of cytochrome C from the mitochondria, 
which subsequently causes apoptosis. Our 
results showed significant mitochondrial 
swelling and collapse of the mitochondrial 
membrane potential only in mitochondria 
isolated from oncology nurses’ lymphocytes 
(data not shown). These events could result 
in mitochondrial permeability transition and 
release of cytochrome C from mitochondria into 
the cytosolic fraction. As shown in Figure 4C, 
significant release of cytochrome C was shown in 
mitochondria isolated from nurses’ lymphocytes 
compared to unexposed blood lymphocyte 
mitochondria.
Discussion
We hypothesized that exposure to 
antineoplastic drugs leads to increased toxicity 
in blood lymphocytes in the hospital nurses 
or staff occupationally exposed to anticancer 
drugs. Through observation and biochemical 
experiments, our study results proved that 
toxicity parameters increased in blood 
lymphocytes of exposed group compared to 
those of unexposed nurses. Through different 
studies show that surface contamination, and 
accordingly the potential for occupational 
exposure to antineoplastic drugs, occurs at 
every stage of the hospital medication system 
(2). Those job categories most likely in risk 
of exposure are nurse, pharmacy technician, 
pharmacy receiver, and pharmacist. Over 11 job 
categories (not including housekeeping) per site 
are potentially at risk of exposure. Several studies 
have shown that exposure to antineoplastic drugs 
can cause toxic effects (2). Dermal exposure has 
been suggested to be the main route of exposure 
(29). In a recently study, was assessed dermal 
exposure to cyclophosphamide. Surprisingly, 
exposure levels detected on the hands during 
Figure 3. GSH (A), GSSG (B) and MDA (C).  Lymphocytes (106 cells/mL) were suspended in the RPMI 1640 at 37 oC. Intracellular 
GSH and extra cellular GSSG were fluorimetrically determined. Also, TBARS formation was expressed as nM concentrations. Each bar 
represents mean ± SEM. Each group consisted of 50 individuals. *** p < 0.001 significant difference compared to the unexposed group.
 
 
 
 
 
 
 
 
 
 
Figure 4 
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nursing tasks were higher than those measured 
in the hospital pharmacy during preparation of 
cyclophosphamide. The positive urine samples 
with detectable cyclophosphamide and other 
anti-neoplastic drugs were observed in hospital 
personals (29). Also studies show that the 
prevalence of needle stick injury (NSI) in Iranian 
nurses is high that likelihood exposure to anti-
neoplastic drugs has increased (30). 
ROS formation was compared between 
occupationally exposed nurseꞌs lymphocytes 
and unexposed. Referring to the results of ROS 
formation status in the present study, it was shown 
that cellular and mitochondrial ROS formation 
was significantly increased in the lymphocytes 
of occupationally exposed group, compared to 
those of unexposed control (P < 0.05) (Figure 
1A). Neoplastic disease studies revealed that 
treatment with anti-neoplastic drugs increases 
ROS and reduces plasma levels of vitamins C 
and E as well as of glutathione peroxidase (31). 
Consumption of variety of anti-cancer drugs 
have been associated with oxidative stress. For 
example, cisplatin induces formation of reactive 
oxygen species (ROS) in renal proximal tubular 
cell mitochondria, eliciting oxidative alterations 
in lipids, proteins, and DNA of this organelle 
(32), while doxorubicin induced cytotoxicity 
has been associated with ROS production and 
in particular to presence of the superoxide 
anion radical and of hydrogen peroxide in 
cardiomyocytes (33). This drug is also able to 
produce reactive nitrogen species. The oxidant 
RNS such as peroxynitrite is known to induce 
protein oxidation and nitration in the absence 
of GSH, eliciting mitochondrial dysfunction 
and eventually leading to irreversible damage 
and severe loss of cellular ATP (34). A recent 
study has also indicated that exposed nurses to 
antineoplastic drug suffer from oxidative stress 
compared to unexposed nurses (35). It is worth 
noting that both drugs are prepared, handled, and 
administered by nursing personnel in hospitals. 
Our results proved that content of glutathione 
and ATP has decreased in occupationally 
exposed nurses lymphocytes in comparison to 
unexposed nurses (Figure 3 and Figure 2B). The 
decreases in lipid peroxidation level found in our 
study may be explained by an increase in ROS 
formation produced by anti-neoplastic drugs in 
Figure 4. SDH activity (A), mitochondrial swelling (B) and cytochrome c (C). Mitochondrial SDH activity were measured by kit at 1 h. 
Mitochondrial swelling was measured at 30 min, by determination of absorbance decline at 540 nm. Cytochrome c release was measured 
by ELISA kit as described in Experimental methods. Each bar represents mean ± SEM. Each group consisted of 50 individuals*** p < 
0.001 significant difference compared to the unexposed group.
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occupationally exposed nurseꞌs lymphocytes, 
such as superoxide anion and hydrogen peroxide, 
which are known to attach to membrane lipids, 
initiating lipid peroxidation. Similarly, increased 
ROS formation may directly oxidize the 
prosthetic protein group or else reacts directly 
with the peptide chain, leading to conformational 
and functional changes in cellular organelles 
such as mitochondria and lysosomes (36-38). 
The results of this study also showed occurrence 
of mitochondrial and lysosomal damages in 
occupationally exposed nurseꞌs lymphocytes, 
compared to the control group ( P < 0.05) (Figure 
1B and Figure 2A).
Previous studies indicated an increased risk 
of a prolonged time to pregnancy among nurses 
with relatively high exposure to antineoplastic 
agents compared with referent nurses (39). In 
addition to the toxicity to reproduction system, 
antineoplastic drugs have been found to have 
carcinogenic potential. Nine antineoplastic 
drugs have been classified by IARC to be 
carcinogenic to humans.  The leukemia risk 
of an oncology nurse after 40 years of dermal 
exposure to cyclophosphamide was estimated to 
be on average of 0.27 (range = 0 - 40) extra cases 
per million oncology nurses (40).
Mitochondria perform significant roles 
in cellular energy metabolism, free radicals 
generation, control of cell death, growth, 
development, integration of signals from 
mitochondria to nucleus and nucleus to 
mitochondria, and various metabolic pathways 
(41, 42). Introduction of mtDNA mutations 
in transformed cells has been associated with 
increased ROS production and tumor growth. 
Studies revealed that increased and altered 
mtDNA plays a role in the development of 
cancer (43).  Mitochondrial alterations have been 
identified in several cancers (44). An increase in 
mtDNA copy number was observed in patients 
with a higher risk for breast cancer (45). Our 
results on isolated mitochondria obtained from 
occupationally exposed nurseꞌs lymphocytes 
showed significant mitochondrial toxic changes 
such as mitochondrial swelling, inhibition of 
SDH and cytochrome C release (Figure 4). 
Mitochondrial alterations have been associated 
with some forms of cancer and an increased risk 
of certain age-related disorders such as heart 
disease, Alzheimer disease, Parkinson disease 
and immunotoxicity  (46). Additionally, our 
results suggest that the gradual and progressive 
occurrence of these alterations in exposed 
oncology drugs may play a role in progression 
of mentioned diseases. 
Our results showed that occupationally 
exposed nurseꞌs lymphocytes were more 
susceptible to oxidative stress than unexposed 
nurses. Finally, isolated mitochondria from 
lymphocytes could be a biomarker for 
determination people at risk of oxidative diseases 
such as cancer and aging.
Acknowledgements
The results presented in this paper were partly 
extracted from thesis of Dr. Elham Yusefi Pharm. 
D graduate of Faculty of Pharmacy, Tabriz 
University of Medical Sciences who performed 
her thesis under supervision of Professor Jalal 
Pourahmad and Professor Mohammad Ali 
Eghbal. The investigation was carried out in 
Professor Pourahmad’s laboratory at the Faculty 
of Pharmacy, Shahid Beheshti University of 
Medical Sciences. The authors received no 
funding from any organization to perform this 
study.
Conflict of Interest
There are no conflicts to disclose.
References
Sessink PJ and Bos RP. Drugs hazardous to healthcare 
workers. Drug Safety. (1999) 20: 347-59.
Hon C-Y, Teschke K, Chua P, Venners S, and 
Nakashima L. Occupational exposure to antineoplastic 
drugs: identification of job categories potentially 
exposed throughout the hospital medication system. 
Safety and health at work. (2011) 2: 273-81.
Siderov J, Kirsa S, and McLauchlan R. Surface 
contamination of cytotoxic chemotherapy preparation 
areas in Australian hospital pharmacy departments. 
Journal of Pharmacy Practice and Research. (2009) 
39: 117-21.
Schmaus G, Schierl R, and Funck S. Monitoring surface 
contamination by antineoplastic drugs using gas 
chromatography-mass spectrometry and voltammetry. 
American journal of health-system pharmacy: AJHP: 
official journal of the American Society of Health-
System Pharmacists. (2002) 59: 956-61.
Cavallo D, Ursini CL, Perniconi B, Di Francesco A, 
(1)
(2)
(3)
(4)
(5)
Lymphocyte Cytotoxicity in Oncology Nurses
51
Giglio M, Rubino FM, Marinaccio A, and Iavicoli S. 
Evaluation of genotoxic effects induced by exposure 
to antineoplastic drugs in lymphocytes and exfoliated 
buccal cells of oncology nurses and pharmacy 
employees. Mutation Research/Genetic Toxicology 
and Environmental Mutagenesis. (2005) 587: 45-51.
Touzin K, Bussieres J-F, Langlois È, and Lefebvre 
M. Evaluation of surface contamination in a hospital 
hematology–oncology pharmacy. Journal of Oncology 
Pharmacy Practice. (2008) 
Gabano E, Ravera M, and Osella D. The drug targeting 
and delivery approach applied to Pt-antitumour 
complexes. A coordination point of view. Current 
medicinal chemistry. (2009) 16: 4544-80.
Bouvard V, Baan R, Straif K, Grosse Y, Secretan B, El 
Ghissassi F, Benbrahim-Tallaa L, Guha N, Freeman C, 
and Galichet L. A review of human carcinogens—Part 
B: biological agents. The lancet oncology. (2009) 10: 
321-2.
Musak L, Smerhovsky Z, Halasova E, Osina O, 
Letkova L, Vodickova L, Polakova V, Buchancova J, 
Hemminki K, and Vodicka P. Chromosomal damage 
among medical staff occupationally exposed to volatile 
anesthetics, antineoplastic drugs, and formaldehyde. 
Scandinavian journal of work, environment & health. 
(2013) 618-30.
Boughattas AB, Bouraoui S, Debbabi F, El Ghazel 
H, Saad A, and Mrizak N. Évaluation du risque 
génotoxique chez les infirmiers manipulant les 
cytostatiques. in Annales de Biologie Clinique. 2010.
Kopjar N, Garaj-Vrhovac V, Kašuba V, Rozgaj R, 
Ramić S, Pavlica V, and Želježić D. Assessment 
of genotoxic risks in Croatian health care workers 
occupationally exposed to cytotoxic drugs: a multi-
biomarker approach. International journal of hygiene 
and environmental health. (2009) 212: 414-31.
Testa A, Giachelia M, Palma S, Appolloni M, Padua 
L, Tranfo G, Spagnoli M, Tirindelli D, and Cozzi 
R. Occupational exposure to antineoplastic agents 
induces a high level of chromosome damage. Lack 
of an effect of GST polymorphisms. Toxicology and 
applied pharmacology. (2007) 223: 46-55.
Wang X, Oldani MJ, Zhao X, Huang X, and Qian D. 
A review of cancer risk prediction models with genetic 
variants. Cancer informatics. (2014) 13: 19.
Pourahmad J and Salimi A. Isolated Human 
Peripheral Blood Mononuclear Cell (PBMC), a Cost 
Effective Tool for Predicting Immunosuppressive 
Effects of Drugs and Xenobiotics. Iranian journal of 
pharmaceutical research: IJPR. (2015) 14: 979.
Hagmar L, Brøgger A, Hansteen I-L, Heim S, Högstedt 
B, Knudsen L, Lambert B, Linnainmaa K, Mitelman 
F, and Nordenson I. Cancer risk in humans predicted 
by increased levels of chromosomal aberrations in 
lymphocytes: Nordic study group on the health risk 
of chromosome damage. Cancer research. (1994) 54: 
2919-22.
Speit G, Ladeira C, Linsenmeyer R, Schütz P, and Högel 
J. Re-evaluation of a reported increased micronucleus 
(6)
(7)
(8)
(9)
(10)
(11)
(12)
(13)
(14)
(15)
(16)
frequency in lymphocytes of workers occupationally 
exposed to formaldehyde. Mutation Research/Genetic 
Toxicology and Environmental Mutagenesis. (2012) 
744: 161-6.
Salimi A, Vaghar-Moussavi M, Seydi E, and 
Pourahmad J. Toxicity of methyl tertiary-butyl ether 
on human blood lymphocytes. Environmental Science 
and Pollution Research. (2016) 23: 8556-64.
Kalantari H, Jalali M, Jalali A, Salimi A, Alhalvachi 
F, Varga B, Juhasz B, Jakab A, Kemeny-Beke A, and 
Gesztelyi R. Protective effect of Cassia fistula fruit 
extract on bromobenzene-induced nephrotoxicity in 
mice. Human & experimental toxicology. (2011) 30: 
1710-5.
Salimi A, Eybagi S, Seydi E, Naserzadeh P, Kazerouni 
NP, and Pourahmad J. Toxicity of macrolide antibiotics 
on isolated heart mitochondria: a justification for their 
cardiotoxic adverse effect. Xenobiotica. (2016) 46: 82-
93.
Pourahmad J, Eskandari MR, Shakibaei R, and 
Kamalinejad M. A search for hepatoprotective activity 
of aqueous extract of Rhus coriaria L. against oxidative 
stress cytotoxicity. Food and Chemical Toxicology. 
(2010) 48: 854-8.
Seydi E, R Rasekh H, Salimi A, Mohsenifar Z, and 
Pourahmad J. Selective Toxicity of Apigenin on 
Cancerous Hepatocytes by Directly Targeting their 
Mitochondria. Anti-Cancer Agents in Medicinal 
Chemistry (Formerly Current Medicinal Chemistry-
Anti-Cancer Agents). (2016) 16: 1576-86.
Hissin PJ and Hilf R. A fluorometric method for 
determination of oxidized and reduced glutathione in 
tissues. Analytical biochemistry. (1976) 74: 214-26.
Salimi A, Ayatollahi A, Seydi E, Khomeisi N, 
and Pourahmad J. Direct toxicity of amyloid beta 
peptide on rat brain mitochondria: preventive role of 
Mangifera indica and Juglans regia. Toxicological & 
Environmental Chemistry. (2015) 97: 1057-70.
Rotem R, Heyfets A, Fingrut O, Blickstein D, Shaklai 
M, and Flescher E. Jasmonates: novel anticancer 
agents acting directly and selectively on human cancer 
cell mitochondria. Cancer research. (2005) 65: 1984-
93.
Salimi A, Roudkenar MH, Sadeghi L, Mohseni A, 
Seydi E, Pirahmadi N, and Pourahmad J. Ellagic 
acid, a polyphenolic compound, selectively induces 
ROS-mediated apoptosis in cancerous B-lymphocytes 
of CLL patients by directly targeting mitochondria. 
Redox biology. (2015) 6: 461-71.
Salimi A, Saharkhiz MP, Motallebi A, Seydi E, Mohseni 
AR, Nazemi M, and Pourahmad J. Standardized 
Extract of the Persian Gulf Sponge, Axinella Sinoxea 
Selectively Induces Apoptosis through Mitochondria 
in Human Chronic Lymphocytic Leukemia Cells. 
Journal of Analytical Oncology. (2015) 4: 132-40.
Talari M, Seydi E, Salimi A, Mohsenifar Z, Kamalinejad 
M, and Pourahmad J. Dracocephalum: novel anticancer 
plant acting on liver cancer cell mitochondria. BioMed 
research international. (2014) 2014: 
(17)
(18)
(19)
(20)
(21)
(22)
(23)
(24)
(25)
(26)
(27)
 Eghbal MA et al. / IJPR (2018), 17 (Special Issue): 43-52
52
Salimi A, Motallebi A, Ayatollahi M, Seydi E, Mohseni 
AR, Nazemi M, and Pourahmad J. Selective toxicity of 
persian gulf sea cucumber holothuria parva on human 
chronic lymphocytic leukemia b lymphocytes by direct 
mitochondrial targeting. Environmental Toxicology. 
(2016). 
Fransman W, Vermeulen R, and Kromhout H. 
Dermal exposure to cyclophosphamide in hospitals 
during preparation, nursing and cleaning activities. 
International archives of occupational and 
environmental health. (2005) 78: 403-12.
Askarian M, Shaghaghian S, and McLaws M-L. 
Needlestick injuries among nurses of Fars province, 
Iran. Annals of epidemiology. (2007) 17: 988-92.
Andreadou I, Sigala F, Iliodromitis EK, Papaefthimiou 
M, Sigalas C, Aligiannis N, Savvari P, Gorgoulis V, 
Papalabros E, and Kremastinos DT. Acute doxorubicin 
cardiotoxicity is successfully treated with the 
phytochemical oleuropein through suppression of 
oxidative and nitrosative stress. Journal of molecular 
and cellular cardiology. (2007) 42: 549-58.
Santandreu FM, Roca P, and Oliver J. Uncoupling 
protein-2 knockdown mediates the cytotoxic effects of 
cisplatin. Free Radical Biology and Medicine. (2010) 
49: 658-66.
Deng S, Kruger A, Kleschyov AL, Kalinowski L, 
Daiber A, and Wojnowski L. Gp91phox-containing 
NAD (P) H oxidase increases superoxide formation by 
doxorubicin and NADPH. Free Radical Biology and 
Medicine. (2007) 42: 466-73.
Wagner BA, Evig CB, Reszka KJ, Buettner GR, 
and Burns CP. Doxorubicin increases intracellular 
hydrogen peroxide in PC3 prostate cancer cells. 
Archives of biochemistry and biophysics. (2005) 440: 
181-90.
Gómez-Oliván LM, Miranda-Mendoza GD, Cabrera-
Galeana PA, Galar-Martínez M, Islas-Flores H, 
SanJuan-Reyes N, Neri-Cruz N, and García-Medina 
S. Oxidative stress induced in nurses by exposure to 
preparation and handling of antineoplastic drugs in 
(28)
(29)
(30)
(31)
(32)
(33)
(34)
(35)
Mexican hospitals: a multicentric study. Oxidative 
medicine and cellular longevity. (2014). 
Denicola A and Radi R. Peroxynitrite and drug-
dependent toxicity. Toxicology. (2005) 208: 273-88.
Kang KA and Hyun JW. Oxidative stress, Nrf2, and 
epigenetic modification contribute to anticancer drug 
resistance. Toxicological research. (2017) 33: 1.
Tran Q, Lee H, Park J, Kim S-H, and Park J. Targeting 
Cancer Metabolism-Revisiting the Warburg Effects. 
Toxicological Research. (2016) 32: 177.
Fransman W, Roeleveld N, Peelen S, de Kort W, 
Kromhout H, and Heederik D. Nurses with dermal 
exposure to antineoplastic drugs: reproductive 
outcomes. Epidemiology. (2007) 18: 112-9.
Meijster T, Fransman W, van Hemmen J, Kromhout 
H, Heederik D, and Tielemans E. A probabilistic 
assessment of the impact of interventions on oncology 
nurses’ exposure to antineoplastic agents. Occupational 
and environmental medicine. (2006) 63: 530-7.
Singh AK, Pandey P, Tewari M, Pandey HP, and 
Shukla HS. Human mitochondrial genome flaws and 
risk of cancer. Mitochondrial DNA. (2014) 25: 329-34.
Kim A. Mitochondria in Cancer Energy Metabolism: 
Culprits or Bystanders? Toxicological research. (2015) 
31: 323.
Chatterjee A, Mambo E, and Sidransky D. 
Mitochondrial DNA mutations in human cancer. 
Oncogene. (2006) 25: 4663-74.
Pourahmad J. Natural compounds target mitochondrial 
alterations in cancer cell: new avenue for anticancer 
research. Iranian journal of pharmaceutical research: 
IJPR. (2014) 13: 1.
Shen J, Platek M, Mahasneh A, Ambrosone CB, and 
Zhao H. Mitochondrial copy number and risk of breast 
cancer: a pilot study. Mitochondrion. (2010) 10: 62-8.
Zapico SC and Ubelaker DH. mtDNA mutations and 
their role in aging, diseases and forensic sciences. 
Aging and disease. (2014) 4: 364-80.
(36)
(37)
(38)
(39)
(40)
(41)
(42)
(43)
(44)
(45)
(46)
This article is available online at http://www.ijpr.ir
